Fesoterodine "add-on" Male Overactive Bladder Study

Clinical trial NCT00546637 · COMPLETED

Trial details

NCT number: NCT00546637
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder Syndrome

Start date: 2007-11-01
Primary completion: 2009-02-01
Enrollment: 947

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.